Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suppressive Oral Acyclovir for Neonatal HSV SEM Disease
NCT00031447Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 1999
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of aciclovir in herpes simplex virus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 1999; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT00031447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031447.